PARP1 and non-Hodgkin lymphoma: Indeed, higher PARP1 expression has been found in several carcinomas, including breast, ovarian, and lung cancers and non-Hodgkin’s lymphoma.10,288 PARP1 can also stimulate ERK activity, promoting proangiogenic and metastatic factors.